The AQP3 Knockout H9 Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout population derived from the H9 human embryonic stem cell line, targeting the aquaporin 3 (AQP3) gene. This model disrupts AQP3 expression across a heterogeneous cell population, providing a robust tool for loss-of-function studies in a pluripotent stem cell context. The polyclonal format captures diverse CRISPR-induced mutations, enabling population-level analyses without the bias of a single clonal isolate, and facilitating investigation of AQP3-dependent phenotypes in both undifferentiated and differentiating cells.
The parental H9 (WA09) human embryonic stem cell line was derived from the inner cell mass of a blastocyst-stage embryo and is well-characterized for its robust pluripotency, capable of differentiating into derivatives of all three germ layers??ectoderm, mesoderm, and endoderm. H9 cells maintain a normal karyotype and express hallmark pluripotency markers such as OCT4, SOX2, and NANOG. This genetic stability and defined differentiation potential make H9 an ideal host for studying gene function in early development, cell fate decisions, and disease mechanisms in a physiologically relevant human model.
AQP3 encodes an aquaglyceroporin that facilitates transmembrane transport of water and glycerol, playing essential roles in cell volume regulation, skin hydration, and metabolic homeostasis. Its expression is transcriptionally regulated by hypertonicity, NF-??B, Sp1, TNF-??, and IL-1??, with activity modulated by ERK1/2 signaling. Downstream, AQP3-mediated glycerol uptake activates MAPK/ERK and PI3K/AKT pathways through interactions with EGFR and actin, and association with lipid raft proteins. This channel also cross-talks with other aquaporins such as AQP1. Disruption of AQP3 in these polyclonal knockout cells uncouples osmotic sensing from MAP2K1/2-ERK1/2 and PI3K-AKT-NF-??B cascades, impairing downstream processes like cell migration, proliferation, and actin cytoskeleton rearrangement.
In the context of H9 pluripotent stem cells, AQP3 knockout provides a powerful model to dissect how glycerol metabolism and osmo-adaptation influence self-renewal and lineage specification. Pluripotent cells are exquisitely sensitive to metabolic and osmotic perturbations; loss of AQP3 may alter glycolytic flux, redox balance, and signaling thresholds that govern differentiation toward ectodermal, mesodermal, or endodermal fates. This model is particularly relevant for investigating mechanisms underlying cancer stem cell-like properties, where AQP3 is frequently upregulated, and for skin biology research given the protein??s role in keratinocyte hydration and barrier function. Furthermore, it enables study of aquaporin-dependent pathways in nephrogenic diabetes insipidus and metabolic syndrome.
Researchers can employ this polyclonal knockout population in a broad range of functional assays. Transcript and protein expression analyses via RT-qPCR, western blotting, and immunofluorescence confirm AQP3 disruption and assess downstream effectors. Functional studies include water permeability assays, glycerol uptake measurements, scratch wound healing assays for migration, and transepithelial electrical resistance (TEER) measurements for barrier integrity. Metabolic flux analysis and flow cytometry for pluripotency markers (OCT4, SSEA-4) further characterize the metabolic and differentiation consequences of AQP3 loss. The model is also suited for drug screening targeting aquaporin-mediated pathways and for investigating osmotic stress in stem cell differentiation. For more details or to discuss custom applications, please contact Ascent Research.
